| Analysis | Metabolite Name | Measured Value | Units | diabetes | time of day |
|---|---|---|---|---|---|
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8003 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8129 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8314 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8473 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.8625 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9227 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 0.9532 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.0137 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.1906 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.2271 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.3024 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.3324 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.4415 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.8772 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (late) POSITIVE ION MODE | 1-palmitoyl-GPE (16:0) | 1.9795 | VolNormImp Area counts | db/db | ZT17 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|